HIF1A and hepatocellular carcinoma: An anti-HIF-1α oligonucleotide EZN-2968 had been tested in advanced solid tumors, lymphoma, and hepatocellular carcinoma (HCC) in different Phase I trials (US National Library of Medicine, 2011; US National Library of Medicine, 2018a; US National Library of Medicine, 2018b).